What You Should Know: Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it raised more than $13 million in Series A financing to transform the way diseases are diagnosed and treatment decisions are made.Taiwania Capital and Debiopharm Innovation Fund co-led the round, with participation from previous investors First Star Ventures, Redalpine Venture Partners, and Pikas. Other new investors include P5 Health
Read More
Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant
Accenture: Data Collaboratives Hold Great Promise for Accelerated Healthcare Progress and Precision Medicine
What You Should Know: - Accenture published Fast-Forwarding Healthcare through Data Collaboratives Report to discover how best health ecosystem players access data to fast-forward healthcare. - Data generated by technical and scientific advances, like connected health devices, consumer health and medical-grade digital apps, individual multi-omics profiling data and the move to cloud storage, holds great promise for accelerated healthcare progress and precision medicine, and data
Read More
Protai Raises $20M to Build an Oncology Drug Discovery Pipeline
What You Should Know: - Protai, a proteomics and AI-powered drug discovery startup revolutionizing the way new drugs are discovered, today announced a $12 million extension of its seed round, bringing the total amount to $20M. - The round includes existing investors Grove Ventures and Pitango Healthcare and was joined by Copenhagen-based Maj Invest Equity Fund. The additional funding will be used to build Protai’s oncology drug discovery pipeline, expand data
Read More
Vysioneer & Pfizer Partner on AI-Powered Oncology Clinical Trials
What You Should Know: - Vysioneer, a provider of applied AI for Oncology, today announced a data-sharing agreement with Pfizer, a global leader in pharmaceuticals. The agreement aims to lay the foundation for the application of AI in oncology clinical trials. As part of the agreement, Vysioneer gains access to one of Pfizer's oncology clinical trial datasets to apply Vysioneer's advanced machine-learning techniques to facilitate the drug efficacy assessment process, thereby allowing Pfizer
Read More
FemTech: Joi Women’s Wellness Launches Nationwide
What You Should Know: - Joi Women’s Wellness (Joi), a modern, femtech proactive approach to women’s health care, today announced the company’s official nationwide launch and availability of its hormone optimization and peptide therapy treatments, as well as the introduction of a new telehealth platform that provides a goals-based, customizable experience to help women own their health journey and manage the hormone and age–related changes to their bodies. - Joi offers health coaching and
Read More
The New “Front Door” to Healthcare Can Only Open Fully with True Interoperability
Some people think of retail pharmacists as standing behind the counter bottling pills, answering insurance questions, or discussing side effects with a customer. But the COVID pandemic fundamentally changed the role of the neighborhood pharmacist, from primarily dispensing medication to increasingly being the source of urgent and primary care for patients. With the successful administration of more than 300 million COVID vaccinations, an ongoing doctor shortage, and
Read More
Withings Unveils Mini At-Home Urine Analysis Platform for Clinical Trials & RPM
What You Should Know: - During a press preview event at CES last night, Withings unveiled, U-Scan, a miniaturized urine health lab that will change the way people and health professionals will monitor vitals from the comfort and privacy of their own bathroom. - U-Scan consists of a technologically advanced pebble-shaped urine analysis reader that sits within the toilet bowl. Its changeable cartridges are designed to assess specific biomarkers without the need for
Read More
Sonde Health Secures $19.25M for Voice-Based Health Monitoring
What You Should Know: - Sonde Health, a Boston, MA-based health technology company committed to bringing accessible health monitoring to everyone raises $19.25 million in a Series B investment round led by Partners Investment, with participation from NEOM Company, KT Corporation, and existing investors, including co-founder PureTech Health and M Ventures. - The AI vocal biomarker company will use the funding to accelerate its commercial growth, expand its platform into new health
Read More
Can Doctors Objectively Quantify and Measure Pain?
Millions of Americans live with acute and chronic pain that affects every aspect of their lives. Pain by itself is an important marker of how a patient is feeling and indicates what kind of medical intervention might be necessary. The healthcare industry needs a clinically acceptable way to objectively measure pain and since pain is a very complex mixture of biochemistry and genetics and it’s unlikely that a laboratory test that directly quantifies pain will be developed. Doctors
Read More
New Liquid Biopsy Detects Breast Cancer at Its Earliest Stages
What You Should Know: - Exai Bio and researchers at UCSF released data demonstrating that Exai’s novel, RNA-based liquid biopsy platform accurately detected breast cancer at the earliest stages and smallest tumor sizes. - Earlier detection of breast cancer is crucial for optimal patient outcomes but cannot always be achieved based on symptoms or mammography. Non-Invasive Blood-Based Platform Delivers Promising Data on Detecting Breast Cancer At It’s Earliest Stages Exai Bio is a
Read More
